Concepedia

Publication | Closed Access

6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma

15

Citations

0

References

2011

Year

No additional data available for this publication yet. Check back later!